Log In
Print this Print this

Duexis, ibuprofen/famotidine (HZT-501)

Also known as: Duexa

  Manage Alerts
Collapse Summary General Information
Company Horizon Pharma plc
DescriptionFixed-dose combination of 800 mg ibuprofen and 26.6 mg famotidine, a histamine H2 receptor (HRH2; H2R) antagonist
Molecular Target Histamine H2 receptor (HRH2) (H2R)
Mechanism of ActionHistamine H2 receptor antagonist
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today